Related Experiment Video
Updated: Mar 1, 2026
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Sentinel Lymph Node Technique in Endometrial Cancer
Allison Staley1, Stephanie A Sullivan2, Emma C Rossi3
1Resident Physician, Department of Obstetrics and Gynecology.
Importance:
Endometrial cancer (EMCA) is the most common gynecologic malignancy, with an estimated 54,000 new cases and 10,000 deaths in the United States in 2015. Lymph node metastasis is the most significant prognostic factor in EMCA. Sentinel lymph node (SLN) mapping has become a well-accepted procedure in surgical oncology and may strike a balance between the risks and benefits of lymphadenectomy.
Objective:
The aim of this study was to review the current literature regarding the history, techniques, and clinical application of SLN mapping in EMCA.
Evidence Acquisition:
Evidence was obtained through systematic literature review through PubMed and ClinicalTrials.gov.
Conclusions:
Sentinel lymph node biopsy for EMCA is an accepted approach to the staging of this cancer; however, a consensus approach to the SLN biopsy technique and pathologic assessment is needed. Surgeons newly adopting the technique should proceed with caution and care to monitor outcomes.
More Related Videos
07:51The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
06:37Multispectral Real-time Fluorescence Imaging for Intraoperative Detection of the Sentinel Lymph Node in Gynecologic Oncology
Published on: October 20, 2010